These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22978290)

  • 21. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles.
    Alves AD; Cavaco JS; Guerreiro F; Lourenço JP; Rosa da Costa AM; Grenha A
    Molecules; 2016 May; 21(6):. PubMed ID: 27240337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological response to micron- and nanometer-sized particles known as potential wear products from artificial hip joints: Part II: Reaction of murine macrophages to corundum particles of different size distributions.
    Kranz I; Gonzalez JB; Dörfel I; Gemeinert M; Griepentrog M; Klaffke D; Knabe C; Osterle W; Gross U
    J Biomed Mater Res A; 2009 May; 89(2):390-401. PubMed ID: 18563824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
    Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
    Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
    Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
    J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.
    Bonecini-Almeida MG; Chitale S; Boutsikakis I; Geng J; Doo H; He S; Ho JL
    J Immunol; 1998 May; 160(9):4490-9. PubMed ID: 9574555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Chicoric Acid and 13-Cis Retinoic Acid in Mycobacterium tuberculosis Infection Control by Human U937 Macrophage.
    Abd-Nikfarjam B; Nassiri-Asl M; Hajiaghayi M; Naserpour Farivar T
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):399-406. PubMed ID: 29704020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic concentrations of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis.
    Chang H; Tsai SY; Chang Y; Chen TL; Chen RM
    Can J Anaesth; 2002 May; 49(5):477-80. PubMed ID: 11983662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis.
    Marcianes P; Negro S; Barcia E; Montejo C; Fernández-Carballido A
    AAPS PharmSciTech; 2019 Dec; 21(1):15. PubMed ID: 31807908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
    Prior S; Gander B; Lecároz C; Irache JM; Gamazo C
    J Antimicrob Chemother; 2004 Jun; 53(6):981-8. PubMed ID: 15102748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity.
    Yadav AB; Misra A
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3740-2. PubMed ID: 17664326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide.
    Darwin KH; Ehrt S; Gutierrez-Ramos JC; Weich N; Nathan CF
    Science; 2003 Dec; 302(5652):1963-6. PubMed ID: 14671303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
    Hare NJ; Chan B; Chan E; Kaufman KL; Britton WJ; Saunders BM
    Proteomics; 2015 Sep; 15(17):3020-9. PubMed ID: 26036210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of direct antimicrobial activity through mammalian toll-like receptors.
    Thoma-Uszynski S; Stenger S; Takeuchi O; Ochoa MT; Engele M; Sieling PA; Barnes PF; Rollinghoff M; Bolcskei PL; Wagner M; Akira S; Norgard MV; Belisle JT; Godowski PJ; Bloom BR; Modlin RL
    Science; 2001 Feb; 291(5508):1544-7. PubMed ID: 11222859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
    Sharma R; Saxena D; Dwivedi AK; Misra A
    Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy.
    Parumasivam T; Chan JG; Pang A; Quan DH; Triccas JA; Britton WJ; Chan HK
    Mol Pharm; 2016 Mar; 13(3):979-89. PubMed ID: 26808409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of iron on the expression of cytokines in macrophages infected with Mycobacterium tuberculosis.
    Serafín-López J; Chacón-Salinas R; Muñoz-Cruz S; Enciso-Moreno JA; Estrada-Parra SA; Estrada-García I
    Scand J Immunol; 2004 Oct; 60(4):329-37. PubMed ID: 15379857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages.
    Hirsch CS; Ellner JJ; Russell DG; Rich EA
    J Immunol; 1994 Jan; 152(2):743-53. PubMed ID: 8283049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2.
    Yang CS; Lee JS; Song CH; Hur GM; Lee SJ; Tanaka S; Akira S; Paik TH; Jo EK
    Cell Microbiol; 2007 Feb; 9(2):382-96. PubMed ID: 16925784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human macrophage host defense against Mycobacterium tuberculosis.
    Liu PT; Modlin RL
    Curr Opin Immunol; 2008 Aug; 20(4):371-6. PubMed ID: 18602003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.